珈凯生物
(920165)
| 流通市值：4.32亿 | | | 总市值：12.47亿 |
| 流通股本：1671.40万 | | | 总股本：4827.44万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 112,374,023.42 | 124,801,568.63 | 100,224,320.18 | 68,996,515.83 |
| 交易性金融资产 | 140,150,027.4 | 30,010,712.33 | 30,019,424.66 | 50,024,684.93 |
| 应收票据及应收账款 | 56,706,832.23 | 47,646,404.31 | 54,324,840.68 | 44,423,543.02 |
| 应收账款 | 56,706,832.23 | 47,646,404.31 | 54,324,840.68 | 44,423,543.02 |
| 预付款项 | 3,849,643.3 | 2,668,001.08 | 2,437,814.54 | 2,621,886.27 |
| 其他应收款合计 | 2,825,811.46 | 2,662,274.07 | 2,479,480.78 | 4,099,095.87 |
| 存货 | 28,698,628.85 | 27,802,294.22 | 21,768,498.94 | 16,982,197.82 |
| 其他流动资产 | 1,308,996.36 | 5,374,137.13 | 6,026,527.22 | 5,040,784.76 |
| 流动资产合计 | 345,913,963.02 | 240,965,391.77 | 217,280,907 | 192,188,708.5 |
| 非流动资产: | | | | |
| 固定资产 | 258,862,410.24 | 264,026,840.42 | 268,527,449.9 | 272,161,807.21 |
| 在建工程 | 210,102.31 | 1,496,513.63 | 325,672.56 | 1,861,844.32 |
| 使用权资产 | 116,531.84 | 233,063.84 | 349,595.84 | 466,127.84 |
| 无形资产 | 20,109,435.82 | 18,438,772.07 | 18,865,978.13 | 19,176,971.14 |
| 长期待摊费用 | 3,465,284.44 | 2,924,950.73 | 2,991,907.78 | 2,990,165.04 |
| 递延所得税资产 | 1,738,996.24 | 1,984,413.36 | 2,726,651.88 | 1,639,043.95 |
| 其他非流动资产 | 357,763.11 | 539,784.13 | 2,180,554.14 | 1,655,250.59 |
| 非流动资产合计 | 284,860,524 | 289,644,338.18 | 295,967,810.23 | 299,951,210.09 |
| 资产总计 | 630,774,487.02 | 530,609,729.95 | 513,248,717.23 | 492,139,918.59 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 11,722,290.95 | 15,068,881.62 | 18,572,318.02 | 12,286,326.22 |
| 应付账款 | 11,722,290.95 | 15,068,881.62 | 18,572,318.02 | 12,286,326.22 |
| 合同负债 | 1,038,004.21 | 1,478,645.38 | 713,978.02 | 1,072,216.08 |
| 应付职工薪酬 | 11,719,899.06 | 12,807,336.22 | 8,426,018.68 | 15,211,636.25 |
| 应交税费 | 6,455,395.34 | 3,604,963.24 | 6,532,730.65 | 5,862,665.57 |
| 其他应付款合计 | 1,341,936.81 | 1,616,337.08 | 1,346,187.55 | 959,498.22 |
| 一年内到期的非流动负债 | 164,307.95 | 318,798.99 | 472,204.5 | 623,158.48 |
| 其他流动负债 | 1,113,326.88 | 546,686.04 | 854,507.23 | 269,861.93 |
| 流动负债合计 | 33,555,161.2 | 35,441,648.57 | 36,917,944.65 | 36,285,362.75 |
| 非流动负债: | | | | |
| 长期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 预计负债 | 1,383,145.61 | 863,485.38 | 921,698.77 | 376,513.28 |
| 递延收益 | 2,801,223.11 | 2,906,268.99 | 3,011,314.87 | 3,116,360.75 |
| 递延所得税负债 | 295,756.44 | 289,009.48 | 304,792.68 | 320,058.08 |
| 非流动负债合计 | 14,480,125.16 | 14,058,763.85 | 14,237,806.32 | 13,812,932.11 |
| 负债合计 | 48,035,286.36 | 49,500,412.42 | 51,155,750.97 | 50,098,294.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 48,274,349 | 41,033,196 | 41,033,196 | 41,033,196 |
| 资本公积 | 353,335,073.23 | 244,442,908.1 | 243,694,885.52 | 242,946,862.94 |
| 盈余公积 | 20,516,598 | 20,516,598 | 20,516,598 | 20,516,598 |
| 未分配利润 | 160,613,180.43 | 175,116,615.43 | 156,848,286.74 | 137,544,966.79 |
| 归属于母公司股东权益合计 | 582,739,200.66 | 481,109,317.53 | 462,092,966.26 | 442,041,623.73 |
| 股东权益合计 | 582,739,200.66 | 481,109,317.53 | 462,092,966.26 | 442,041,623.73 |
| 负债和股东权益合计 | 630,774,487.02 | 530,609,729.95 | 513,248,717.23 | 492,139,918.59 |
| 公告日期 | 2026-10-28 | 2026-08-20 | 2026-04-21 | 2026-03-20 |
| 审计意见(境内) | | | | 标准无保留意见 |